Holen Sie sich die Stockscreener-App
4.20
0.00%
0.00
Schlusskurs vom Vortag:
$4.20
Offen:
$4.51
24-Stunden-Volumen:
3,429
Relative Volume:
0.02
Marktkapitalisierung:
$31.12M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+5.00%
1M Leistung:
-3.23%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.10
$4.51
1-Wochen-Bereich:
$3.91
$4.51
52-Wochen-Spanne:
$3.4962
$50.82
Radiopharm Theranostics Ltd Adr Stock (RADX) Company Profile
Firmenname
Radiopharm Theranostics Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie RADX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RADX
Radiopharm Theranostics Ltd Adr
|
4.20 | 31.12M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.03 | 129.44B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.52 | 61.42B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
615.11 | 38.44B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
269.81 | 33.29B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
241.75 | 26.95B | 3.81B | -644.79M | -669.77M | -6.24 |
Radiopharm Theranostics Ltd Adr Stock (RADX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-12 | Eingeleitet | B. Riley Securities | Buy |
Radiopharm Theranostics Ltd Adr Aktie (RADX) Neueste Nachrichten
Radiopharm advances brain cancer diagnosis with new trial By Investing.com - Investing.com South Africa
Radiopharm advances brain cancer diagnosis with new trial - Investing.com
Radiopharm Theranostics says new data confirms positive tumour uptake - Biotech Dispatch
Radiopharm Theranostics Engages in Key Healthcare Conferences - TipRanks
B.Riley sets $15 target on Radiopharm Theranostics stock - Investing.com India
Radiopharm Theranostics Announces Director’s Interest Change and Securities Cessation - TipRanks
Radiopharm joins B Riley Radiopharma Conference - Investing.com
Radiopharm reveals positive brain metastases trial data - Investing.com India
Top 3 Health Care Stocks You'll Regret Missing This Month - Benzinga
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday - Benzinga
Radiopharm completes preclinical tests for cancer drug RAD 402 - Investing.com
United States shares lower at close of trade; Dow Jones Industrial Average down 0.54% - Investing.com India
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.54% - Investing.com
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.54% - Investing.com UK
Radiopharm Achieves Nasdaq Listing of American Depositary Shares - GlobeNewswire
Radiopharm Theranostics Set for Nasdaq Debut Under RADX Symbol | RADX Stock News - StockTitan
Radiopharm Theranostics Reports Promising Study Results - MSN
Radiopharm Theranostics (ASX:RAD) Advances Cancer Trials and Expands US Presence - Kalkine Media
Radiopharm Theranostics Marks Progress and Expands US Access - TipRanks
Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited - Business Wire
DBDeutsche Bk Latest Stock News & Market Updates - StockTitan
Market Data Center - Barron's
U.S. STOCKS - The Wall Street Journal
Finanzdaten der Radiopharm Theranostics Ltd Adr-Aktie (RADX)
Es liegen keine Finanzdaten für Radiopharm Theranostics Ltd Adr (RADX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
5.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):